These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16418124)

  • 1. Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: the impact of social network factors, side effects, and perceived treatment efficacy.
    Demas PA; Thea DM; Weedon J; McWayne J; Bamji M; Lambert G; Schoenbaum EE
    Women Health; 2005; 42(1):99-115. PubMed ID: 16418124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.
    Demas PA; Webber MP; Schoenbaum EE; Weedon J; McWayne J; Enriquez E; Bamji M; Lambert G; Thea DM
    Pediatrics; 2002 Sep; 110(3):e35. PubMed ID: 12205285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin.
    Havens PL; Cuene BE; Hand JR; Gern JE; Sullivan BW; Chusid MJ
    Pediatr Infect Dis J; 1997 Sep; 16(9):871-5. PubMed ID: 9306482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
    Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
    Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey.
    Abatemarco DJ; Catov JM; Cross H; Delnevo C; Hausman A
    J Health Care Poor Underserved; 2008 Aug; 19(3):814-28. PubMed ID: 18677072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire.
    Msellati P; Ramon R; Viho I; Noba V; Mandelbrot L; Dabis F; Welffens Ekra C
    AIDS; 1998 Jul; 12(10):1257-8. PubMed ID: 9677183
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
    Palmer AL; Gay H; Currier MM
    J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Bhadrakom C; Simonds RJ; Mei JV; Asavapiriyanont S; Sangtaweesin V; Vanprapar N; Moore KH; Young NL; Hannon WH; Mastro TD; Shaffer N
    AIDS; 2000 Mar; 14(5):509-16. PubMed ID: 10780713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation.
    Wortley PM; Lindegren ML; Fleming PL
    MMWR Recomm Rep; 2001 May; 50(RR-6):17-28. PubMed ID: 15580801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing perinatal human immunodeficiency virus transmission: factors influencing women's intentions toward zidovudine therapy.
    Sowell RL; Murdaugh CL; Addy C; Moneyham L; Tavokoli A; Misener T
    South Med J; 2001 Dec; 94(12):1177-84. PubMed ID: 11811856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project.
    Ickovics JR; Wilson TE; Royce RA; Minkoff HL; Fernandez MI; Fox-Tierney R; Koenig LJ;
    J Acquir Immune Defic Syndr; 2002 Jul; 30(3):311-5. PubMed ID: 12131568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: perinatally acquired HIV/AIDS--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(46):1086-92. PubMed ID: 9385878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.
    Wiznia AA; Crane M; Lambert G; Sansary J; Harris A; Solomon L
    JAMA; 1996 May; 275(19):1504-6. PubMed ID: 8622226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.